Showing results (21-30 of 106) with videos related to
Sort By:
Pageof 11
Journal of Cancer Research and Clinical Oncology|February 23, 2010
Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathwaysTongsen Zheng, Jiabei Wang, Xuan Song, et al.Cancer Discovery|November 1, 2024
Exploring the Interplay of Diet, Obesity, Immune Function, and CancerYumin Fu, Xinyu Guo, Linmao Sun, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 28, 2010
Disruption of p73-MDM2 binding synergizes with gemcitabine to induce apoptosis in HuCCT1 cholangiocarcinoma cell line with p53 mutationTongsen Zheng, Jiabei Wang, Xi Chen, et al.Oncotarget|March 2, 2015
HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cellsLihua Wu, Haiyang Yu, Yuhan Zhao, et al.Elife|August 15, 2024
Exploring the role of the immune microenvironment in hepatocellular carcinoma: Implications for immunotherapy and drug resistanceYumin Fu, Xinyu Guo, Linmao Sun, et al.International Journal of Biological Sciences|January 3, 2024
LncRNA CRNDE Drives the Progression of Hepatocellular Carcinoma by inducing the Immunosuppressive NicheXianying Li, Shuhang Liang, Mingming Fei, et al.Sensors (Basel, Switzerland)|August 14, 2025
Equivalent Self-Noise Suppression of Distributed Hydroacoustic Sensing System Using SDM Signals Based on Multi-Core FiberJiabei Wang, Hongcan Gu, Peng Wang, et al.The Journal of Pharmacology and Experimental Therapeutics|July 1, 2005
Chronic morphine up-regulates G alpha12 and cytoskeletal proteins in Chinese hamster ovary cells expressing the cloned mu opioid receptorHeng Xu, Xiaoying Wang, Darin Zimmerman, et al.Journal of Gastroenterology and Hepatology|January 26, 2011
MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitroJiabei Wang, Tongsen Zheng, Xi Chen, et al.Journal of Hepatocellular Carcinoma|September 8, 2025
Efficacy and Safety of Different Doses of Bevacizumab Combined with Atezolizumab in Unresectable Hepatocellular CarcinomaShaobo Zhang, Jiabei Wang, Zebin Zhu, et al.Pageof 11